Exodus Point Capital Management, LP Bridge Bio Pharma, Inc. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $342,470 - $462,185	14,890 New	14,890 $377,000
Q1 2023 May 11, 2023	BUY	$7.17 - $18.55 $90,514 - $234,175	12,624 New	12,624 $209,000
Q3 2022 Nov 10, 2022	SELL	$7.94 - $12.36 $580,660 - $903,899	-73,131 Reduced 30.97%	162,981 $1.62 Million
Q2 2022 Aug 19, 2022	BUY	$5.21 - $12.14 $749,479 - $1.75 Million	143,854 Added 155.93%	236,112 $2.14 Million
Q1 2022 May 13, 2022	BUY	$7.34 - $17.16 $677,173 - $1.58 Million	92,258 New	92,258 $936,000
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $300,352 - $1.41 Million	-26,393 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $1.24 Million - $1.7 Million	26,393 New	26,393 $1.24 Million
Q2 2021 Aug 16, 2021	SELL	$46.47 - $63.93 $506,011 - $696,133	-10,889 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$55.47 - $72.35 $604,012 - $787,819	10,889 New	10,889 $671,000

291

171M

10.4M

2.37M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.52B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.